Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Ottawa
$105,000.00
The impact of fracture-related infection and bacteriophage therapy on skeletal regeneration
FY 2021-22
Summary
More than six million bone fractures occur in North America each year, and fracture-related infection (FRI) remains a serious risk, engendering long-term health complications. Up to 30% of skeletal trauma patients are afflicted with FRI, which can result in repeat surgeries, loss-of-function, and even amputation. An FRI must be eliminated both swiftly and completely for proper bone regeneration and patient recovery. Historically, FRI management has consisted of a combination of wound cleaning and antibiotic regimens; however, antibiotic therapy is a short-term solution as antimicrobial-resistant pathogens are projected to surpass cancer as the leading cause of death by 2050. Bacteriophages - natural, bacteria-targeting viruses which seek out and eliminate infection - offer a promising alternative FRI treatment strategy and have been demonstrated as safe in human clinical trials. To explore the potential of bacteriophage therapy to treat FRI, a preclinical model must first be established. We propose to develop an FRI-bacteriophage model in mice, the first of its kind, which will examine the potential of bacteriophage therapy to eliminate FRI and improve skeletal stem cell (SSC)-mediated tissue regeneration. Developing a reliable FRI-bacteriophage model is a critical step towards demonstrating the utility of bacteriophage therapy as an alternative to antibiotics in treating FRI, and will be essential to reach clinical applications. Ultimately, development of this model will improve outcomes for skeletal trauma patients as we strive to prevent loss of limb, decrease recovery time, and improve patient quality-of-life.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
458903
Name
Short Spencer J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The impact of fracture-related infection and bacteriophage therapy on skeletal regeneration
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Bacteriophage; Bone Regeneration; Confocal Microscopy; Fracture-Related Infection; Imunohistochemistry; Mouse Model; Osteomyelitis; Skeletal Stem Cell
Abstract
More than six million bone fractures occur in North America each year, and fracture-related infection (FRI) remains a serious risk, engendering long-term health complications. Up to 30% of skeletal trauma patients are afflicted with FRI, which can result in repeat surgeries, loss-of-function, and even amputation. An FRI must be eliminated both swiftly and completely for proper bone regeneration and patient recovery. Historically, FRI management has consisted of a combination of wound cleaning and antibiotic regimens; however, antibiotic therapy is a short-term solution as antimicrobial-resistant pathogens are projected to surpass cancer as the leading cause of death by 2050. Bacteriophages - natural, bacteria-targeting viruses which seek out and eliminate infection - offer a promising alternative FRI treatment strategy and have been demonstrated as safe in human clinical trials. To explore the potential of bacteriophage therapy to treat FRI, a preclinical model must first be established. We propose to develop an FRI-bacteriophage model in mice, the first of its kind, which will examine the potential of bacteriophage therapy to eliminate FRI and improve skeletal stem cell (SSC)-mediated tissue regeneration. Developing a reliable FRI-bacteriophage model is a critical step towards demonstrating the utility of bacteriophage therapy as an alternative to antibiotics in treating FRI, and will be essential to reach clinical applications. Ultimately, development of this model will improve outcomes for skeletal trauma patients as we strive to prevent loss of limb, decrease recovery time, and improve patient quality-of-life.
Competitiondate
202111
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Short, Spencer J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~